LRI Investments’s Integra LifeSciences IART Stock Holding History

LRI Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.98K	Hold	500	–	–	﹤0.01%	987
2026 Q1	$4.71K	Hold	500	–	–	﹤0.01%	1105
2025 Q4	$6.21K	Hold	500	–	–	﹤0.01%	992
2025 Q3	$7.17K	Hold	500	–	–	﹤0.01%	949
2025 Q2	$6.13K	Hold	500	–	–	﹤0.01%	963
2025 Q1	$11K	Hold	500	–	–	﹤0.01%	782
2024 Q4	$11.3K	Sell	500 -40	-7%	-$873	﹤0.01%	765
2024 Q3	$12.6K	Buy	540 +325	+151%	+$7.53K	﹤0.01%	739
2024 Q2	$6.26K	Buy	+215	New	+$6.38K	﹤0.01%	840

Other funds holding IART

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MAA

Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

CMA

Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return

LRI Investments's IART Position: Q2 2026 in Review

LRI Investments held its Integra LifeSciences (IART) position steady in Q2 2026 at 500 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #987.

LRI Investments first reported a position in IART in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.6K in Q3 2024. 16 funds tracked by Wall St. Rank hold IART as of Q2 2026.

LRI Investments held 500 shares of Integra LifeSciences worth $8.98K as of Q2 2026.
LRI Investments left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #987 holding.
LRI Investments first reported a position in Integra LifeSciences in Q2 2024 and has held it in 9 quarters since.
LRI Investments's Integra LifeSciences position peaked at $12.6K in Q3 2024.
16 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.